PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT EYEGATE PHARMACEUTICALS, INC.Eyegate Pharmaceuticals Inc • August 10th, 2021 • Pharmaceutical preparations
Company FiledAugust 10th, 2021 IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 9, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from EyeGate Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrants is issued pursuant to that certain engagement letter, dated as of August 5, 2021, by and between the Company
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 10th, 2021 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 9, 2021, between EyeGate Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL EyeGate Pharmaceuticals, Inc.Letter Agreement • August 10th, 2021 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2021 Company Industry Jurisdiction